Will This Analyst Upgrade Help Edwards Lifesciences (EW) Stock Today? (Update)

Update (9:43 a.m.): Updated with Wednesday market open information.

NEW YORK ( TheStreet) --  JMP Securities upgraded  Edwards Lifesciences  ( EW) to "outperform" from "market perform," increased its estimates and set a $97 price target following positive physician surveys.

The stock was up 0.73% to $81.30 at 9:44 a.m. on Wednesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

EW Chart

EW data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

If you liked this article you might like

Edwards Lifesciences: Cramer's Top Takeaways

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)

Hold on Concert's Hair Loss Trials Pushes Shares Down 10%

Edwards Lifesciences Is Not Skipping A Beat

Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock